The Europe Clinical Trial Supply & Logistics Market would witness market growth of 7.1% CAGR during the forecast period (2022-2028).
Pharmaceutical and biotechnology companies are investing more in R&D and expanding their facilities in preparation for the approval and release of new pharmaceuticals on the market. High R&D expenditures and robust supply and logistics infrastructure will likely boost the likelihood of successful treatment or medicine. For example, DHL Freight increased its network in Germany in July 2022 by purchasing a new facility in Mettmann, near Düsseldorf.
This endeavor was conducted following the recent opening of a new facility in Erlensee, near Frankfurt, Germany, and the acquisition of a site from the logistics company Leupold in Gochsheim, around Würzburg, Germany. The participants continually extend their facilities, collaborate, and engage in mergers, partnerships, and acquisitions.
These are essential strategic initiatives that are changing the dynamics of the industry. For instance, in June 2022, Catalent announced that it would extend its main packaging capabilities at its clinical supply facility in Japan, by constructing an elevated blister packaging line to complement its already automated bottling line.
This market is driven by the rapid growth in the number of cancer cases and the increased focus of researchers on the utilization of biologics for cancer treatment. In 2018, there were an estimated 3,9 million new cases of cancer and 1,9 million cancer-related deaths in Europe. Female breast cancer (523,000 new cases, 13% of all cancer cases), colorectum cancer (500,000 new cases, 13%), lung cancer (470,000 new cases, 12%), and prostate cancer (450,000 new cases, 12%) were the most prevalent cancers on the continent. Together they accounted for nearly half of the total cancer burden.
Biologic therapies utilize the immune system and the body's ability to fight cancer or heal healthy tissue following treatment, making them increasingly popular over conventional cancer treatment methods. Thus, the increased incidence of cancer is driving the expansion of biologics, which is anticipated to experience significant growth for the aforementioned reasons. Consequently, these factors fuel the expansion of the Clinical Trial Supply & Logistics Market in Europe.
The Germany market dominated the Europe Clinical Trial Supply & Logistics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $348.7 Million by 2028.The UK market is anticipated to grow at a CAGR of 6.2% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 7.9% during (2022 - 2028).
Based on End-user, the market is segmented into Pharmaceuticals, Biologicals and Medical Device. Based on Therapeutic Area, the market is segmented into Cardiovascular Diseases, Respiratory Diseases, CNS & Mental Disorders, Oncology and Others. Based on Phase, the market is segmented into Phase III, Phase II, Phase I and Phase IV. Based on Service, the market is segmented into Logistics & Distribution, Comparator Sourcing, Storage & Retention, Packaging, Labeling, & Blinding, Manufacturing and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Catalent, Inc., Marken (United Parcel Service of America, Inc.), Piramal Enterprises Limited, FedEx Corporation, Inizio Group Limited (Clayton, Dubilier & Rice), Parexel International Corporation (Phoenix Parentco, Inc.), Almac Group, Movianto (Walden Group SAS), and Deutsche Post DHL Group (The Deutsche Post AG)
Pharmaceutical and biotechnology companies are investing more in R&D and expanding their facilities in preparation for the approval and release of new pharmaceuticals on the market. High R&D expenditures and robust supply and logistics infrastructure will likely boost the likelihood of successful treatment or medicine. For example, DHL Freight increased its network in Germany in July 2022 by purchasing a new facility in Mettmann, near Düsseldorf.
This endeavor was conducted following the recent opening of a new facility in Erlensee, near Frankfurt, Germany, and the acquisition of a site from the logistics company Leupold in Gochsheim, around Würzburg, Germany. The participants continually extend their facilities, collaborate, and engage in mergers, partnerships, and acquisitions.
These are essential strategic initiatives that are changing the dynamics of the industry. For instance, in June 2022, Catalent announced that it would extend its main packaging capabilities at its clinical supply facility in Japan, by constructing an elevated blister packaging line to complement its already automated bottling line.
This market is driven by the rapid growth in the number of cancer cases and the increased focus of researchers on the utilization of biologics for cancer treatment. In 2018, there were an estimated 3,9 million new cases of cancer and 1,9 million cancer-related deaths in Europe. Female breast cancer (523,000 new cases, 13% of all cancer cases), colorectum cancer (500,000 new cases, 13%), lung cancer (470,000 new cases, 12%), and prostate cancer (450,000 new cases, 12%) were the most prevalent cancers on the continent. Together they accounted for nearly half of the total cancer burden.
Biologic therapies utilize the immune system and the body's ability to fight cancer or heal healthy tissue following treatment, making them increasingly popular over conventional cancer treatment methods. Thus, the increased incidence of cancer is driving the expansion of biologics, which is anticipated to experience significant growth for the aforementioned reasons. Consequently, these factors fuel the expansion of the Clinical Trial Supply & Logistics Market in Europe.
The Germany market dominated the Europe Clinical Trial Supply & Logistics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $348.7 Million by 2028.The UK market is anticipated to grow at a CAGR of 6.2% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 7.9% during (2022 - 2028).
Based on End-user, the market is segmented into Pharmaceuticals, Biologicals and Medical Device. Based on Therapeutic Area, the market is segmented into Cardiovascular Diseases, Respiratory Diseases, CNS & Mental Disorders, Oncology and Others. Based on Phase, the market is segmented into Phase III, Phase II, Phase I and Phase IV. Based on Service, the market is segmented into Logistics & Distribution, Comparator Sourcing, Storage & Retention, Packaging, Labeling, & Blinding, Manufacturing and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Catalent, Inc., Marken (United Parcel Service of America, Inc.), Piramal Enterprises Limited, FedEx Corporation, Inizio Group Limited (Clayton, Dubilier & Rice), Parexel International Corporation (Phoenix Parentco, Inc.), Almac Group, Movianto (Walden Group SAS), and Deutsche Post DHL Group (The Deutsche Post AG)
Scope of the Study
Market Segments Covered in the Report:
By End-user
- Pharmaceuticals
- Biologicals
- Medical Device
By Therapeutic Area
- Cardiovascular Diseases
- Respiratory Diseases
- CNS & Mental Disorders
- Oncology
- Others
By Phase
- Phase III
- Phase II
- Phase I
- Phase IV
By Service
- Logistics & Distribution
- Comparator Sourcing
- Storage & Retention
- Packaging, Labeling, & Blinding
- Manufacturing
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc
- Catalent, Inc
- Marken (United Parcel Service of America, Inc.)
- Piramal Enterprises Limited
- FedEx Corporation
- Inizio Group Limited (Clayton, Dubilier & Rice)
- Parexel International Corporation (Phoenix Parentco, Inc.)
- Almac Group
- Movianto (Walden Group SAS)
- Deutsche Post DHL Group (The Deutsche Post AG)
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Clinical Trial Supply & Logistics Market, by End-user
1.4.2 Europe Clinical Trial Supply & Logistics Market, by Therapeutic Area
1.4.3 Europe Clinical Trial Supply & Logistics Market, by Phase
1.4.4 Europe Clinical Trial Supply & Logistics Market, by Service
1.4.5 Europe Clinical Trial Supply & Logistics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Scenario and Composition
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Clinical Trial Supply & Logistics Market
Chapter 4. Europe Clinical Trial Supply & Logistics Market by End-user
4.1 Europe Pharmaceuticals Market by Country
4.2 Europe Biologicals Market by Country
4.3 Europe Medical Device Market by Country
Chapter 5. Europe Clinical Trial Supply & Logistics Market by Therapeutic Area
5.1 Europe Cardiovascular Diseases Market by Country
5.2 Europe Respiratory Diseases Market by Country
5.3 Europe CNS & Mental Disorders Market by Country
5.4 Europe Oncology Market by Country
5.5 Europe Others Market by Country
Chapter 6. Europe Clinical Trial Supply & Logistics Market by Phase
6.1 Europe Phase III Market by Country
6.2 Europe Phase II Market by Country
6.3 Europe Phase I Market by Country
6.4 Europe Phase IV Market by Country
Chapter 7. Europe Clinical Trial Supply & Logistics Market by Service
7.1 Europe Logistics & Distribution Market by Country
7.2 Europe Comparator Sourcing Market by Country
7.3 Europe Storage & Retention Market by Country
7.4 Europe Packaging, Labeling, & Blinding Market by Country
7.5 Europe Manufacturing Market by Country
7.6 Europe Others Market by Country
Chapter 8. Europe Clinical Trial Supply & Logistics Market by Country
8.1 Germany Clinical Trial Supply & Logistics Market
8.1.1 Germany Clinical Trial Supply & Logistics Market by End-user
8.1.2 Germany Clinical Trial Supply & Logistics Market by Therapeutic Area
8.1.3 Germany Clinical Trial Supply & Logistics Market by Phase
8.1.4 Germany Clinical Trial Supply & Logistics Market by Service
8.2 UK Clinical Trial Supply & Logistics Market
8.2.1 UK Clinical Trial Supply & Logistics Market by End-user
8.2.2 UK Clinical Trial Supply & Logistics Market by Therapeutic Area
8.2.3 UK Clinical Trial Supply & Logistics Market by Phase
8.2.4 UK Clinical Trial Supply & Logistics Market by Service
8.3 France Clinical Trial Supply & Logistics Market
8.3.1 France Clinical Trial Supply & Logistics Market by End-user
8.3.2 France Clinical Trial Supply & Logistics Market by Therapeutic Area
8.3.3 France Clinical Trial Supply & Logistics Market by Phase
8.3.4 France Clinical Trial Supply & Logistics Market by Service
8.4 Russia Clinical Trial Supply & Logistics Market
8.4.1 Russia Clinical Trial Supply & Logistics Market by End-user
8.4.2 Russia Clinical Trial Supply & Logistics Market by Therapeutic Area
8.4.3 Russia Clinical Trial Supply & Logistics Market by Phase
8.4.4 Russia Clinical Trial Supply & Logistics Market by Service
8.5 Spain Clinical Trial Supply & Logistics Market
8.5.1 Spain Clinical Trial Supply & Logistics Market by End-user
8.5.2 Spain Clinical Trial Supply & Logistics Market by Therapeutic Area
8.5.3 Spain Clinical Trial Supply & Logistics Market by Phase
8.5.4 Spain Clinical Trial Supply & Logistics Market by Service
8.6 Italy Clinical Trial Supply & Logistics Market
8.6.1 Italy Clinical Trial Supply & Logistics Market by End-user
8.6.2 Italy Clinical Trial Supply & Logistics Market by Therapeutic Area
8.6.3 Italy Clinical Trial Supply & Logistics Market by Phase
8.6.4 Italy Clinical Trial Supply & Logistics Market by Service
8.7 Rest of Europe Clinical Trial Supply & Logistics Market
8.7.1 Rest of Europe Clinical Trial Supply & Logistics Market by End-user
8.7.2 Rest of Europe Clinical Trial Supply & Logistics Market by Therapeutic Area
8.7.3 Rest of Europe Clinical Trial Supply & Logistics Market by Phase
8.7.4 Rest of Europe Clinical Trial Supply & Logistics Market by Service
Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc. (Pantheon)
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Acquisition and Mergers:
9.1.5.4 Geographical Expansions:
9.1.6 SWOT Analysis
9.2 Catalent, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Regional & Segmental Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Product Launches and Product Expansions:
9.2.5.2 Acquisition and Mergers:
9.2.5.3 Geographical Expansions:
9.3 Marken (United Parcel Service of America, Inc.)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.4 Piramal Enterprises Limited
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Recent strategies and developments:
9.4.4.1 Product Launches and Product Expansions:
9.5 Deutsche Post DHL Group (The Deutsche Post AG)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Recent strategies and developments:
9.5.4.1 Acquisition and Mergers:
9.6 FedEx Corporation
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.7 Inizio Group Limited (Clayton, Dubilier & Rice)
9.7.1 Company Overview
9.8 Parexel International Corporation (Phoenix Parentco, Inc.)
9.8.1 Company Overview
9.9 Almac Group
9.9.1 Company Overview
9.10. Movianto (Walden Group SAS)
9.10.1 Company Overview
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Catalent, Inc.
- Marken (United Parcel Service of America, Inc.)
- Piramal Enterprises Limited
- FedEx Corporation
- Inizio Group Limited (Clayton, Dubilier & Rice)
- Parexel International Corporation (Phoenix Parentco, Inc.)
- Almac Group
- Movianto (Walden Group SAS)
- Deutsche Post DHL Group (The Deutsche Post AG)
Methodology
LOADING...
